-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$34.30113.18% Upside
Syndax Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. has been rated by research analysts at Scotiabank, UBS, Citigroup, Bank of America Securities, Barclays, Jefferies in the past 90 days.